Skin structure and function: The body's primary defense against infection

Infectious Diseases in Clinical Practice

Volumn 16, Issue 2, 2008, Pages 113-117

  Brodell, Lindsey A ^a   Rosenthal, Kenneth S ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Northeast Ohio Medical University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADAPTIVE IMMUNITY; DENDRITIC CELL; EPIDERMIS; EXTRACELLULAR MATRIX; HUMAN; INNATE IMMUNITY; KERATINOCYTE; LANGERHANS CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW; SKIN INFECTION; SKIN PROTECTION; SKIN STRUCTURE; SKIN WATER LOSS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; T LYMPHOCYTE; WART VIRUS;

EID: 40949146168     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/IPC.0b013e3181660bf4     Document Type: Review

References (33)

1. Marks R. The stratum corneum barrier: the final frontier. J Nutr. 2004;134(8 suppl):2017S-2021S.
2. Lee SH, Jeong SK, Ahn SK. An update of the defensive barrier function of skin. Yonsei Med J. 2006;47(3):293-306.
3. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125:183-200.
4. Sandilands A. Filagrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Investigative Derm. 2007;127:1282-1284.
5. Elias PM. The skin barrier as an innate immune element. Semin Immunopathol. 2007;29(1):3-14.
6. Bruckner-Tuderman L, Hopfner B, Hammami-Hauasli N. Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix Biol. 1999;18(1):43-54.
7. Rosenthal KS. Vaccines Make Good Immune Theater: immunization as described in a three act play. Infect Dis Clin Pract. 2006;14:35-45.
8. Pivarcis A, Nagy I, Kemeny L. Innate immunity in the skin: how keratinocytes fight against pathogens. Curr Immunol Rev. 2005;1:29-42.
9. Salmon JK, Armstrong CA, Ansel JC. The skin as an immune organ. West J Med. 1994;160(2):146-152.
10. Braff MH, Bardan A, Nizet V, et al. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol. 2005;125(1):9-13.
11. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3(9):710-720.
12. Murakami M, Ohtake T, Dorschner RA, et al. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol. 2002;119(5):1090-1095.
13. Harder J, Schroder JM. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem. 2002;277(48):46779-46784.
14. Sallenave JM. Antimicrobial activity of antiproteinases. Biochem Soc Trans. 2002;30(2):111-115.
15. Kapetanovic R, Cavaillon JM. Early events in innate immunity in the recognition of microbial pathogens. Expert Opin Biol Ther. 2007;7(6):907-918.
16. Saalbach A, Klein C, Sleeman J, et al. Dermal fibroblasts induce maturation of dendritic cells. J Immunol. 2007;178(8):4966-4974.
17. Rosenthal KS. Are microbial symptoms "self-inflicted"? The consequences of immunopathology. Infect Dis Clin Pract. 2005;13:306-311.
18. Wolff K, Goldsmith LA, Katz SI, et al. Fitzpatrick's Dermatology in General Medicine. New York, NY: McGraw Hill, Health Prof Div;2008.
19. Que JU, Hentges DJ. Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice. Infect Immun. 1985;48(1):169-174.
20. Pirotta MV, Garland SM. Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics. J Clin Microbiol. 2006;44(9):3213-3217.
21. Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect. 1995;31(1):13-24.
22. Simpanya M. Dermatophytes: their taxonomy, ecology, and pathogenicity. In: Kushwaha RKS, Guarro J, eds. Biology of Dermatophytes and Other Keratinophilic Fungi. Bilbao, Spain: Revista Iberoamericana de Micología; 2000:1-12.
23. Curran JP, Al-Salihi FL. Neonatal staphylococcal scalded skin syndrome: massive outbreak due to an unusual phage type. Pediatrics. 1980;66(2):285-290.
24. Ladhani S, Joannou CL, Lochrie DP, et al. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev. 1999;12(2):224-242.
25. Voyich JM, Otto M, Mathema B, et al. Is Panton Valentine Leukocidin the Major Virulence Determinant in Community-Associated Mehicillin-Resistant Staphylococcus aureus disease? J Inf Dis. 2006;194:1761-1770.
26. Voyich JM, Braghton KR, Sturdevant DE, et al. Insights into Mechanisms Used by Staphylococcus aureus to Avoid Destruction by Staphylococcus aureus to Avoid Destruction by Human Neutrophils. J Immunol. 2005;175:3907-3919.
27. Seguchi T, Chang-Yi C, Kusuda S, et al. Decreased expression of filaggrin in atopic skin. Arch Derm Res. 1996;288(8):442-446.
28. Sandilands A. Fillagrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Investigative Derm. 2007;127:1282-1284.
29. Sugarman JL, Fluhr JW, Fowler AJ, et al. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer assisted estimates for extent of disease. Arch Dermatology. 2003;39:1417-1422.
30. Ong PY, Ohtake T, Brandt C, et al. Endegenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis. NEJM. 2002;347(15):1151-1160.
31. Rigopoulos D, Paparizos V, Katsambas A. Cutaneous markers of HIV infection. Clin Dermatol. 2004;22(6):487-98.
32. Lilic D. New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr Opin Infect Dis. 2002;15:143-147.
33. Nguyen DM, Mascola L, Bancroft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emergency Med News. 2005;27(3):54-59.